珠海联邦制药_Providing professional financial news and data related to 珠海联邦制药, committed to creating a comprehensive and efficient information access channel for users | NewTimeSpace

Finance
China Longyuan Power (00916.HK): Implementation of 2025 Equity Distribution, Final Dividend of RMB 0.625 per 10 Shares
Finance
Shenwan Hongyuan (06806.HK): Subsidiary’s RMB 3.6 Billion Corporate Bonds Listed on Shenzhen Stock Exchange
Finance
New Focus (00360.HK): Appointment of Hord Capital as Independent Financial Adviser
Finance
China Everbright Greentech (01257.HK): Entered Framework Agreements for Hazardous Waste Disposal Services Covering 2026 to 2028
Finance
Muyuan Co., Ltd. (02714.HK): Completes Corporate Name Change
Finance
CGII HLDGS (01940.HK): Completion of Loan Assignment
Finance
Guofu Hydrogen Energy (02582.HK): H-share Full Circulation Granted Listing Approval by HKEX
Finance
Wise Wealth Resources Investment (00007.HK): Appointment of Hao Xiaohui as Executive Director and Co-Chairman, Xu Shiping Re-designated as Co-Chairman
Finance
Fosun Pharma (02196.HK): Controlled Subsidiary’s HLX3902 Injection Obtains Clinical Trial Approval
Finance
Xunhe Group (01591.HK): Expected Annual Loss to Widen to HK$13 Million – HK$16 Million

Scan QR Code

Download App